AGNARGENICA THERAPEUTICS LIMITEDMarket sensitive

Argenica Receives $3.97m R&D Tax Incentive Cash Rebate

Date and time
Announcement type
Periodic Reports
Show details
Category
Reports
Report codes
03014
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASXOpen original PDFAGN announcement history

Recent AGN announcements